Gregory Lambert

CEO, TargEDys, France
When
4th-5th Nov 2021
Where
San Diego, USA
Sheraton San Diego Hotel & Marina
The two-day meeting hosted numerous presentations on probiotics discovery and product development, as well as prebiotics, diet and nutrition. Alongside a number of case studies on digestive health, metabolic diseases, ageing, skin health and allergy, the conference highlighted the developments in personalised nutrition and explored strategies for commercialisation. The FDA had been invited to speak on the regulatory aspects of probiotic products.
The meeting was once again collocated with the 8th Microbiome R&D and Business Collaboration Forum: USA and 2nd Skin & Cosmeceuticals Congress: USA. Attendees could track-hop between all three events and have access to 100 presentations.
A panel discussion explored the various sources of funding for microbiome products. Expert-led round tables provided delegates with a forum to discuss a range of topics such as the challenges for microbiome-based precision medicine or the skin microbiome and the future of “clean beauty.”
“there was a wide spectrum of presentations for Microbiome area, high level of presenters, especially in Bioinformatics and Computational biology”
“I got to learn about up-to-date research and product development”
“great structure, liked all the talks running in parallel”
This programme is designed to create a collaborative environment in which delegates could enduring relationships across the full range of microbiome and probiotics research.
Probiotics Discovery and Product Development
Prebiotics, Diet and Personalised Nutrition
Commercialisation and Regulation
Gut Microbiota for Health / Disease
Composition and modulation of the microbiome
Tools and Technologies for Microbiome Discovery
Beyond the gut
Women & Infant Health
Business Collaboration – Regulation & investment
Skin Health & the Microbiome
Cosmetics and Commercial Strategy
Assistant Professor, Department of Molecular Biology & Biochemistry University of California, Irvine
Director of Scientific Affairs, Cargill Health Technologies
Executive Director, Nutrition+HealthCARE
Chief Medical Officer, VP Research and Development, Adare Pharmaceuticals
Director Nutrition Research Center for Human Nutrition, Cleveland Clinic
Assistant Professor of Medicine / Nephrology, Associate Program Director for Research, Internal Medicine Residency Program, University of Buffalo, SUNY
Global Medical Affairs Manager, Bayer Consumer Health
Director, Research & Development, Clasando Bioscience
Assistant Professor of Surgery, Mayo Clinic
Postdoctoral Fellow, Routy Lab, University of Montreal
Faculty and Principal Investigator School of Biochemistry and Cell Biology and Investigator APC Microbiome Ireland
Pfizer Research Chair, Co-director of Sentinel North’s Microbiome thematic projects, Department of Medicine Faculty of Medicine, Laval University
Co-Founder, Quoram Innovations
Professor, Departments of Food Science & Technology and Viticulture & Enology, UC Davis
Co-Founder, The Gut Stuff
Co-Founder, The Gut Stuff
CEO, TargEDys, France
Director of R&D, Seed Health
Vice President for Pre-Clinical and Clinical Research and Development, Human Metabolome Technologies
Executive Director, Center for Microbiome Innovation, UC San Diego
Assistant Professor, Department of Molecular Biology & Biochemistry University of California, Irvine
Director of Scientific Affairs, Cargill Health Technologies
Executive Director, Nutrition+HealthCARE
Chief Medical Officer, VP Research and Development, Adare Pharmaceuticals
Director Nutrition Research Center for Human Nutrition, Cleveland Clinic
Assistant Professor of Medicine / Nephrology, Associate Program Director for Research, Internal Medicine Residency Program, University of Buffalo, SUNY
Global Medical Affairs Manager, Bayer Consumer Health
Director, Research & Development, Clasando Bioscience
Assistant Professor of Surgery, Mayo Clinic
Postdoctoral Fellow, Routy Lab, University of Montreal
Faculty and Principal Investigator School of Biochemistry and Cell Biology and Investigator APC Microbiome Ireland
Pfizer Research Chair, Co-director of Sentinel North’s Microbiome thematic projects, Department of Medicine Faculty of Medicine, Laval University
Co-Founder, Quoram Innovations
Professor, Departments of Food Science & Technology and Viticulture & Enology, UC Davis
Co-Founder, The Gut Stuff
Co-Founder, The Gut Stuff
CEO, TargEDys, France
Director of R&D, Seed Health
Vice President for Pre-Clinical and Clinical Research and Development, Human Metabolome Technologies
Executive Director, Center for Microbiome Innovation, UC San Diego
Do you have something to add to the 2020 agenda? Please email [email protected].
Download the 2020 AgendaThe agenda in brief
What you will get
3 for the price of 2 offer
Discount applied automatically when registering 3 places at once.
Not applicable for solution provider companies or compatible with any other offers or discount codes.
Option 1 – Please phone +44 (0) 1865 671957 ext. 207 and we will take your details over the phone
Option 2 – Please complete the form below to pay online
Organisations offering services and/or business & technology solutions and business consultants please contact Gavin Hambrook to discuss participation at this meeting.
The fees shown are available to industry, academics and not for profit organisations.
To help us comply with GDPR regulations please register using your official institution email address and not a personal email.
$1,099.00
Standard registration for those not in the categories below
$599.00
$1,299.00
Full access to presentations and discussion rooms, as well as enhanced networking with the attendees.
Our sponsorship packages offer a wide range of attendance options to suit your budget and business needs in order to maximise return on investment.
If there is any other way you would like to sponsor or increase branding for your company at the event, please get in touch and we will be able to offer you a bespoke service.
Select which delegates you would like to meet in a series of prearranged twenty-minute one-to-one meetings, held during breakout sessions from the main conference agenda. Our conference team will be available at the sessions to ensure all your meetings take place on time.
Host your own half or full day pre or post event workshop to a dedicated audience around a subject of your choice. Global Engage will assist with the marketing of your workshop to provide a guaranteed audience.
Market to our event database and / or increase brand awareness through taking a poster position or sponsoring one of the refreshment breaks, lunches, drinks receptions or poster sessions. This can be supplemented by branding options such as placing your logo on the attendee lanyards or conference bags.
Showcase your technologies and products throughout the conference in the dedicated exhibition areas where all refreshment breaks and lunches take place, as well as the networking drinks reception at the end of day one.
Options include:
For further details please contact
Gavin Hambrook
Telephone +44 (0) 1865 849841 or
email [email protected]
RB is driven by its purpose to protect, heal and nurture in a relentless pursuit of a cleaner, healthier world. We fight to make access to the highest-quality hygiene, wellness and nourishment a right, not a privilege, for everyone.
RB is proud to have a stable of trusted household brands found in households in more than 190 countries. These include Enfamil, Nutramigen, Mucinex, Dettol, Durex, Lysol, Digestive Advantage, Bodi-Ome, and more.
For more information visit https://www.rb.com/
EpiCor whole food fermentate manufactured by Cargill Health Technologies is a postbiotic ingredient clinically shown to support the immune system and beneficially modulate the gut microbiota. Backed by over 75 years of fermentation expertise, EpiCor is made through a natural proprietary process that creates a unique fingerprint of metabolites. Inspired by a real-life health discovery and supported by clinical research, EpiCor helps people live more healthy days.
https://www.cargill.com/feedingintelligence/technology
×Human Metabolome Technologies (HMT) is a CRO metabolomics company partnering with clients using our patented capillary electrophoresis (CE-MS) platforms. We are a global company with offices in USA, EU and Japan.
HMT enables our clients to discovery critical pathways for biomarker discovery, enhance drug development, perform microbiome screening and uncover mechanisms of action through the profiling of over 2,000 polar metabolites using high resolution, high performance CE-MS and providing LC-MS solutions for hundreds of lipophilic metabolites.
http://humanmetabolome.com/en/
×
Biose Industrie has been producing microbes as a drug at their site in Aurillac for over 60 years. Founded by pharmacists and microbiologists, for the last 3 years we have focussed on the microbiome revolution as a CDMO, applying our deep understanding of the entire process from discovery to commercialization.
With a fundamental belief that health is managed by the beneficial collaboration between human cells and microbes, we use our skills for the product development and manufacturing of Live Biotherapeutic Products (LBPs).
×bitBiome provides “microbial single-cell genomic analysis” as a service for various industries/academia researchers, from basic research to product development.
Our proprietary single-cell, whole-genome analytical platform called bit-MAP enables strain-level differentiation and functional analyses with high accuracy, broad spectrum of bacteria, and high throughput.
It delivers unprecedented strain-level genomics with functional insights into microbiome not available with the existing technologies.
https://www.bitbiome.co.jp/en/
LYSANDO AG is the world leader in the development of unique antimicrobial proteins, Artilysin®s, to combat gram-positive and gram-negative bacteria. Our mission is to introduce the Artilysin® Platform Technology as the answer to the increasing threat of antibiotic resistant and persistent bacterial infections. As Artilysin®s are resistant stable, safe for the microbiome and can be tailored towards the customers´ specific requirements, Lysando AG has a solution, suitable for every customer.
×Bio-Me is transforming microbiome analysis by making it possible to analyze hundreds of samples in less than a day, with high resolution and reproducibility and at an affordable cost. Combined with an exclusive biobank and extensive patient database, Bio-Me’s Precision Microbiome Profiling platform (PMP™) enables the development of clinical tests that will improve health and well-being worldwide.
×TNO is a research and technology innovation institute with established capabilities and track record in determining relationships between diet or drugs, gut microbiome and host health. With a suite of advanced technologies we offer comprehensive approaches to address our customers’ questions on product functionality and microbiome related health. These technologies and their applications include i-screen, InTESTine TM (ex vivo technologies), organoids and gut-on-a-chip for in depth in vitro studies.
https://www.tno.nl/en/focus-areas/healthy-living/roadmaps/biomedical-health/microbiome/
×BioVox is a specialized life sciences news and communication platform keeping you up to date on the rapidly evolving life sciences sector in Belgium and on global scientific and industry trends. BioVox brings exclusive news, in-depth interviews, opinions, and insights on healthcare, agriculture and the bio-based economy.
×BlueSEQ Partners is a specialized global consulting firm focused on the Life Sciences, Digital Biology, and Genomics markets. Their unique blend of Business Management, Technology Understanding, and Strategy and Execution capabilities is what separates them from other consulting firms.
The BlueSEQ Partners group offers customized consulting teams to help their clients gain access to relevant industry C-level expertise, which many of their consultants have achieved over many years’ worth of successful management and scientific operations.
×Cardea Bio is developing a new generation of (bio)technology infrastructure based on proprietary biology-gated transistors (“Cardean transistors”). Cardean transistors leverage biocompatible graphene instead of silicon and replace optical signal observations with direct electrical molecular signal analysis. Until now, life science data was comprised of static snapshot datasets. With Cardean transistors, the company and its Innovation Partners can generate streaming multi-omics data to measure real-time biological signals. Cardea is now manufacturing chips at scale and partners have started to significantly expand the amount, type and quality of biological data they capture by building products that Conduct Biology™.
×Global Information, Inc. is an information service company holding offices in 6 countries and have sales agency contracts with over 300 research companies around the world. We sell 30,000 market research reports published by these publishers and accept custom-made researches.
×Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts, and their current and future position in the marketplace.
×Pharma Journalist is a paramount B2b online magazine platform exhibiting targeted and succinct information concerning the world of Pharmaceutical Industry therefore keeping a tab on the updated and latest updates and trends concerning the field.
×PharmaVOICE magazine provides readers with insightful and thought-provoking commentary about the challenges and trends impacting the life-sciences industry in a multiple-perspective format through articles covering a range of issues from molecule through market. PharmaVOICE’s more than 41,000 BPA-qualified subscribers are also kept abreast of the latest trends and information through additional media resources, including WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts.
×World Pharma Today is a leading Magazine featuring the latest industry developments for the Pharmaceutical C-level executives.
×